Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 134

    1.

    Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1.

    Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz D, Eisenbarth G; for the Diabetes Prevention Trial–Type 1 Study Group.

    Diabetes Care. 2009 Dec;32(12):2269-2274. Epub 2009 Sep 9.PMID: 19741189 [PubMed - as supplied by publisher]Related articles

    2.

    Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articles

    3.

    Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.

    Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC.

    Blood. 2009 Mar 12;113(11):2547-56.PMID: 19282464 [PubMed - indexed for MEDLINE]Related articles

    4.

    The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.

    Couluris M, Mayer JL, Freyer DR, Sandler E, Xu P, Krischer JP.

    J Pediatr Hematol Oncol. 2008 Nov;30(11):791-7.PMID: 18989154 [PubMed - indexed for MEDLINE]Related articles

    5.

    Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individuals.

    Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC.

    Blood. 2008 Oct 9. [Epub ahead of print]PMID: 18845791 [PubMed - as supplied by publisher]Related articlesFree article

    6.

    An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants.

    Richesson RL, Lee HS, Cuthbertson D, Lloyd J, Young K, Krischer JP.

    Contemp Clin Trials. 2009 Jan;30(1):55-62. Epub 2008 Sep 7.PMID: 18804556 [PubMed - indexed for MEDLINE]Related articles

    7.

    An automated standardized system for managing adverse events in clinical research networks.

    Richesson RL, Malloy JF, Paulus K, Cuthbertson D, Krischer JP.

    Drug Saf. 2008;31(10):807-22. Review.PMID: 18759506 [PubMed - indexed for MEDLINE]Related articles

    8.

    An automated communication system in a Contact Registry for persons with rare diseases: tools for retaining potential clinical research participants.

    Richesson RL, Young K, Lloyd J, Adams T, Guillette H, Malloy J, Krischer JP.

    AMIA Annu Symp Proc. 2007 Oct 11:1094.PMID: 18694191 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

    Merkel PA, Cuthbertson DD, Hellmich B, Hoffman GS, Jayne DR, Kallenberg CG, Krischer JP, Luqmani R, Mahr AD, Matteson EL, Specks U, Stone JH; Vasculitis Clinical Research Consortium.

    Ann Rheum Dis. 2009 Jan;68(1):103-6. Epub 2008 Jul 29.PMID: 18664546 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

    Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cross-sectional multicenter study of patients with urea cycle disorders in the United States.

    Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, Kerr DS, Diaz GA, Seashore MR, Lee HS, McCarter RJ, Krischer JP, Batshaw ML; Urea Cycle Disorders Consortium of the Rare Diseases Clinical Research Network.

    Mol Genet Metab. 2008 Aug;94(4):397-402. Epub 2008 Jun 17.PMID: 18562231 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Heterogeneous but "standard" coding systems for adverse events: Issues in achieving interoperability between apples and oranges.

    Richesson RL, Fung KW, Krischer JP.

    Contemp Clin Trials. 2008 Sep;29(5):635-45. Epub 2008 Mar 5.PMID: 18406213 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparing heterogeneous SNOMED CT coding of clinical research concepts by examining normalized expressions.

    Andrews JE, Patrick TB, Richesson RL, Brown H, Krischer JP.

    J Biomed Inform. 2008 Dec;41(6):1062-9. Epub 2008 Feb 5.PMID: 18328789 [PubMed - indexed for MEDLINE]Related articles

    14.

    Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

    Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K; Japanese Center of the Rare Lung Diseases Consortium.

    Am J Respir Crit Care Med. 2008 Apr 1;177(7):752-62. Epub 2008 Jan 17.PMID: 18202348 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Safety of purified isoflavones in men with clinically localized prostate cancer.

    Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R, Kang L, Xu P, Pow-Sang J.

    Nutr Cancer. 2007;59(2):169-75.PMID: 18001211 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.

    Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R, Kang L, Xu P, Pow-Sang J.

    Nutr Cancer. 2007;59(2):163-8.PMID: 18001210 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

    Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Role of insulin resistance in predicting progression to type 1 diabetes.

    Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2007 Sep;30(9):2314-20. Epub 2007 May 29.PMID: 17536068 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    TEDDY--The Environmental Determinants of Diabetes in the Young: an observational clinical trial.

    Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B.

    Ann N Y Acad Sci. 2006 Oct;1079:320-6.PMID: 17130573 [PubMed - indexed for MEDLINE]Related articles

    21.

    Relative validity of a dietary interview for assessing infant diet and compliance in a dietary intervention trial.

    Vähätalo L, Bärlund S, Hannila ML, Uusitalo U, Pigg HM, Salonen M, Nucci A, Krischer JP, Knip M, Akerblom HK, Virtanen SM.

    Matern Child Nutr. 2006 Jul;2(3):181-7.PMID: 16881930 [PubMed - indexed for MEDLINE]Related articles

    22.

    Use of SNOMED CT to represent clinical research data: a semantic characterization of data items on case report forms in vasculitis research.

    Richesson RL, Andrews JE, Krischer JP.

    J Am Med Inform Assoc. 2006 Sep-Oct;13(5):536-46. Epub 2006 Jun 23.PMID: 16799121 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

    Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.

    Redondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum C, Palmer JP, Cuthbertson D, Eisenbarth GS, Krischer JP, Schatz D; Diabetes Prevention Trial Type 1 Study Group.

    J Clin Endocrinol Metab. 2006 May;91(5):1705-13. Epub 2006 Feb 7.PMID: 16464953 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

    Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.

    Cancer. 2005 Dec 15;104(12):2807-16.PMID: 16284991 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

    Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E.

    Diabetes Care. 2005 May;28(5):1068-76.PMID: 15855569 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes.

    Redondo MJ, Fain PR, Krischer JP, Yu L, Cuthbertson D, Winter WE, Eisenbarth GS; DPT-1 Study Group.

    J Autoimmun. 2004 Nov;23(3):275-9.PMID: 15501398 [PubMed - indexed for MEDLINE]Related articles

    28.

    A randomized controlled trial to increase cancer screening among attendees of community health centers.

    Roetzheim RG, Christman LK, Jacobsen PB, Cantor AB, Schroeder J, Abdulla R, Hunter S, Chirikos TN, Krischer JP.

    Ann Fam Med. 2004 Jul-Aug;2(4):294-300.PMID: 15335126 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Selection of patients for clinical trials: an interactive web-based system.

    Fink E, Kokku PK, Nikiforou S, Hall LO, Goldgof DB, Krischer JP.

    Artif Intell Med. 2004 Jul;31(3):241-54.PMID: 15302090 [PubMed - indexed for MEDLINE]Related articles

    30.

    Male sex increases the risk of autoimmunity but not type 1 diabetes.

    Krischer JP, Cuthbertson DD, Greenbaum C; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2004 Aug;27(8):1985-90.PMID: 15277428 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Colorectal cancer screening among a sample of community health center attendees.

    Christman LK, Abdulla R, Jacobsen PB, Cantor AB, Mayhew DY, Thompson KS, Krischer JP, Roetzheim RG.

    J Health Care Poor Underserved. 2004 May;15(2):281-93.PMID: 15253379 [PubMed - indexed for MEDLINE]Related articles

    32.

    Lysophospholipids are potential biomarkers of ovarian cancer.

    Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP, Arango H, Hoffman MS, Martino M, Wakeley K, Griffin D, Blanco RW, Cantor AB, Xiao YJ, Krischer JP.

    Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1185-91.PMID: 15247129 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

    Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS.

    J Clin Endocrinol Metab. 2003 Jan;88(1):103-8.PMID: 12519837 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband.

    Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP.

    Ann N Y Acad Sci. 2002 Apr;958:254-8.PMID: 12021118 [PubMed - indexed for MEDLINE]Related articles

    35.

    Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patients.

    Zeidler A, Raffel LJ, Costin G, Shaw SJ, Buchanan TA, Noble J, Rotter JI, Palmer J, Krischer JP, Wait C, Maclaren NK.

    J Clin Endocrinol Metab. 2001 Oct;86(10):4957-62.PMID: 11600569 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.

    Duffner PK, Horowitz ME, Krischer JP, Burger PC, Cohen ME, Sanford RA, Friedman HS, Kun LE.

    Neuro Oncol. 1999 Apr;1(2):152-61. Review. No abstract available. PMID: 11554387 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Economic analysis of cancer treatment costs: another tool for oncology managers.

    Chirikos TN, Ruckdeschel JC, Krischer JP.

    J Oncol Manag. 2001 Jul-Aug;10(3):11-7.PMID: 11548179 [PubMed - indexed for MEDLINE]Related articles

    38.

    Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

    Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators.

    Diabetes. 2001 Aug;50(8):1735-40.PMID: 11473032 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Impact of clinical trials on the cost of cancer care.

    Chirikos TN, Ruckdeschel JC, Krischer JP.

    Med Care. 2001 Apr;39(4):373-83.PMID: 11329524 [PubMed - indexed for MEDLINE]Related articles

    40.

    Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

    Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group.

    Diabetes. 2001 Feb;50(2):470-6.PMID: 11272162 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes.

    Chase HP, Cuthbertson DD, Dolan LM, Kaufman F, Krischer JP, Schatz DA, White NH, Wilson DM, Wolfsdorf J.

    J Pediatr. 2001 Feb;138(2):244-9.PMID: 11174623 [PubMed - indexed for MEDLINE]Related articles

    42.

    Effects of health insurance and race on breast carcinoma treatments and outcomes.

    Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP.

    Cancer. 2000 Dec 1;89(11):2202-13.PMID: 11147590 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Effects of health insurance and race on colorectal cancer treatments and outcomes.

    Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP.

    Am J Public Health. 2000 Nov;90(11):1746-54.PMID: 11076244 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    The effects of physician supply on the early detection of colorectal cancer.

    Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Ayanian JZ, Krischer JP.

    J Fam Pract. 1999 Nov;48(11):850-8.PMID: 10907621 [PubMed - indexed for MEDLINE]Related articles

    45.

    Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection.

    Roetzheim RG, Pal N, van Durme DJ, Wathington D, Ferrante JM, Gonzalez EC, Krischer JP.

    J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):211-8.PMID: 10906640 [PubMed - indexed for MEDLINE]Related articles

    46.

    Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1.

    Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1255-60.PMID: 10720072 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.

    Mulne AF, Ducore JM, Elterman RD, Friedman HS, Krischer JP, Kun LE, Shuster JJ, Kadota RP.

    J Pediatr Hematol Oncol. 2000 Jan-Feb;22(1):41-4.PMID: 10695820 [PubMed - indexed for MEDLINE]Related articles

    48.

    Therapeutic controversy: prevention and treatment of diabetes in children.

    Rosenbloom AL, Schatz DA, Krischer JP, Skyler JS, Becker DJ, Laporte RE, Libman I, Pietropaolo M, Dosch HM, Finberg L, Muir A, Tamborlane WV, Grey M, Silverstein JH, Malone JI.

    J Clin Endocrinol Metab. 2000 Feb;85(2):494-522. Review. No abstract available. PMID: 10690847 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Effects of health insurance and race on early detection of cancer.

    Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP.

    J Natl Cancer Inst. 1999 Aug 18;91(16):1409-15.PMID: 10451447 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study.

    Kung FH, Harris MB, Krischer JP.

    Med Pediatr Oncol. 1999 Mar;32(3):225-6. No abstract available. PMID: 10064193 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...